| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/05/2014 | CN103550718A Traditional Chinese medicine composition for treating lung cancer |
| 02/05/2014 | CN103550706A Applications of different elution parts of phlegm-reducing and dysphagia-treating powder, dryness-moistening soup, adenophora stricta and radix ophiopogonis soup as well as qi-tonifying and spleen-strengthening soup in medicines for treating esophagus cancers |
| 02/05/2014 | CN103550697A Traditional Chinese medicine for treating hysteromyoma |
| 02/05/2014 | CN103550696A Medicine for treating lung cancer |
| 02/05/2014 | CN103550695A Medicament for treating breast cancer |
| 02/05/2014 | CN103550678A External essential oil composition for treating mammary gland hyperplasia and mammary gland tumor |
| 02/05/2014 | CN103550673A Primary liver cancer treatment traditional Chinese medicine composition |
| 02/05/2014 | CN103550670A Traditional Chinese medicine honeyed pill for treating rectal cancer and preparation method thereof |
| 02/05/2014 | CN103550663A Preparation method and application of aplotaxis carminative pill |
| 02/05/2014 | CN103550633A Traditional Chinese medicine for treating stomach cancer of disharmony between liver and stomach type and preparation method thereof |
| 02/05/2014 | CN103550626A Traditional Chinese medicine for preventing postoperative recurrence of colon tumor |
| 02/05/2014 | CN103550607A Traditional Chinese medicine composition for treating chorionic epithelioma |
| 02/05/2014 | CN103550517A Medicine for treating liver cancer |
| 02/05/2014 | CN103550507A Traditional Chinese medicine for treating leukemia |
| 02/05/2014 | CN103550506A Traditional Chinese medicine composition cooperatively used in radiotherapy |
| 02/05/2014 | CN103550494A Traditional Chinese medicine composition, preparation method and application thereof and preparation containing composition |
| 02/05/2014 | CN103550472A Health-protection prescription for cancer patient |
| 02/05/2014 | CN103550468A Medicament for health protection after tumor surgery, and preparation method thereof |
| 02/05/2014 | CN103550466A Preparation method and application of Yougui pill |
| 02/05/2014 | CN103550433A Extraction method of saffron crocus essence substances |
| 02/05/2014 | CN103550330A Traditional Chinese medicine preparation for treating uterine fibroid |
| 02/05/2014 | CN103550323A Traditional Chinese medicine extract with antitumor activity as well as preparation method and use thereof |
| 02/05/2014 | CN103550313A New application of total glucosides of paeony as EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor |
| 02/05/2014 | CN103550299A Traditional Chinese medicinal composition for treating hysteromyoma |
| 02/05/2014 | CN103550293A Litsea martabanica extract and preparation method and application thereof |
| 02/05/2014 | CN103550291A Formula and preparation use method of anticancer traditional Chinese medicine |
| 02/05/2014 | CN103550264A Method for extracting Ganoderma lucidum essences |
| 02/05/2014 | CN103550257A Preparation method of fresh toad skin ultra-fine powder |
| 02/05/2014 | CN103550246A Busulfan composition lyophilized powder for injection |
| 02/05/2014 | CN103550245A Aclarubicin composition freeze-dried powder injection for injection |
| 02/05/2014 | CN103550243A Application of atractylodes macrocephalaon polysaccharide in medicaments or healthcare products for improving kuffer cell immune function |
| 02/05/2014 | CN103550242A Pharmaceutical composition for treating hepatic fibrosis and preparation method thereof |
| 02/05/2014 | CN103550233A Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival |
| 02/05/2014 | CN103550231A Application of grincamycin B in preparing anti-glioma drugs |
| 02/05/2014 | CN103550218A Pyridone gpr119 g protein-coupled receptor agonists |
| 02/05/2014 | CN103550209A Application of thiazolidone derivative in preparing anti-rhabdomyosarcoma medicines |
| 02/05/2014 | CN103550208A Application of thiazolidone derivative in preparing anti-colon-cancer medicines |
| 02/05/2014 | CN103550206A Resveratrol indirubin medicinal composition, controlled-release microcapsules and application thereof |
| 02/05/2014 | CN103550192A Application of natural compound Magnolol in preparation of medicines for treating tumor migration and invasion |
| 02/05/2014 | CN103550180A Dasatinib tablet and preparation process thereof |
| 02/05/2014 | CN103550162A Preparation method of targeted ferroferric oxide-porphyrin containing composite nanoparticles |
| 02/05/2014 | CN103550161A Resveratrol loaded polyurethane micro-nano particle and preparation method thereof |
| 02/05/2014 | CN103550159A Novel solid forms of bendamustine hydrochloride |
| 02/05/2014 | CN103550157A Preparation method of epidoxorubicin lipidosome and application of epidoxorubicin lipidosome in resisting tumors |
| 02/05/2014 | CN103550147A Ganoderma lucidum polysaccharide injection and preparation method thereof |
| 02/05/2014 | CN103550138A Sorafenib organogel and preparation method thereof |
| 02/05/2014 | CN103549650A Toxicity attenuation cigarette with pain easing and nerve soothing effects |
| 02/05/2014 | CN103054981B External traditional Chinese medicine for treating abdominal malignant tumours |
| 02/05/2014 | CN102988611B Preparation method and application of antihypertension tablet |
| 02/05/2014 | CN102764426B Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof |
| 02/05/2014 | CN102690270B Pyrimidine compound and purpose thereof |
| 02/05/2014 | CN102618612B Preparation method for black-bone chicken peptide for chemotherapy, attenuation and synergia and application of black-bone chicken peptide |
| 02/05/2014 | CN102600247B Corydalis saxicola bunting alkaloid extract and preparation method thereof |
| 02/05/2014 | CN102397270B Application of glucal and glucal derivative in preparation of drugs |
| 02/05/2014 | CN102302507B Medicinal composition for directional controlled release of trace elements and preparation method and application |
| 02/05/2014 | CN101903365B Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting KSP kinesin activity |
| 02/04/2014 | US8642834 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| 02/04/2014 | US8642779 Compositions useful as inhibitors of protein kinases |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642613 Treatment for leukemia and idiopathic aplastic anemia |
| 02/04/2014 | US8642608 Quinazoline derivatives as VEGF inhibitors |
| 02/04/2014 | US8642607 4H-chromen-4-one compounds as modulators of protein kinases |
| 02/04/2014 | US8642604 Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents |
| 02/04/2014 | US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors |
| 02/04/2014 | US8642584 Method of using PI3K and MEK modulators |
| 02/04/2014 | US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642036 Treatment with anti-ErbB2 antibodies |
| 02/04/2014 | US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS) |
| 02/04/2014 | US8642007 Method and compound for treatment of cancer using phosphorous-32 labeled DNA |
| 02/04/2014 | CA2753405C Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 02/04/2014 | CA2706742C Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 02/04/2014 | CA2702297C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/04/2014 | CA2620032C Polymer conjugates of k-252a and derivatives thereof |
| 02/04/2014 | CA2618633C Adenine derivatives |
| 02/04/2014 | CA2608171C Use of quinolinone compounds for treating drug resistant cancers |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 01/30/2014 | WO2014018953A1 Inauhzin analogues that induce p53, inhibit cell growth, and have antitumor activity |
| 01/30/2014 | WO2014018919A1 Seriniquinones, melanoma-specific anticancer agents |
| 01/30/2014 | WO2014018874A1 Method for treating skin cancer |
| 01/30/2014 | WO2014018862A1 Pharmaceutical compositions comprising a heat shock protein inhibitor and a|purine de novo synthesis inhibitor for treating rheumatoid arthritis or cancer |
| 01/30/2014 | WO2014018807A1 Peptide epoxyketone compounds |
| 01/30/2014 | WO2014018765A1 Therapeutic compounds |
| 01/30/2014 | WO2014018725A1 Pharmaceutical combinations of a cdk4/6 inhibitor and a b-raf inhibitor |
| 01/30/2014 | WO2014018671A1 Therapeutic compounds for the treatment of cancer |
| 01/30/2014 | WO2014018625A1 Anti-kit antibodies and uses thereof |
| 01/30/2014 | WO2014018620A1 Methods and compounds for reducing threonyl-trna synthetase activity |
| 01/30/2014 | WO2014018619A1 Methods and compounds for increasing threonyl-trna synthetase activity |
| 01/30/2014 | WO2014018113A1 Oncolytic virus therapy for resistant tumors |
| 01/30/2014 | WO2014017928A1 Organic compounds |
| 01/30/2014 | WO2014017659A1 Agent for treating or controlling recurrence of acute myelogenous leukemia |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014017491A1 Fusion gene of cep55 gene and ret gene |
| 01/30/2014 | WO2014017087A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014016830A1 Process and intermediates for the preparation of abiraterone acetate |
| 01/30/2014 | WO2014016464A1 Use of mycobacterium brumae to treat bladder cancer |
| 01/30/2014 | WO2014016434A1 Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk |